- Investing Ideas
- /
- Australian Healthcare Undervalued Stocks Based On Cash Flows
Australian Healthcare Undervalued Stocks Based On Cash Flows
Results
3
1 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
3 companies
PolyNovo
Market Cap: AU$891.2m
Designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally.
New
PNV
AU$1.29
7D
2.4%
1Y
-50.0%
Regis Healthcare
Market Cap: AU$2.4b
Engages in the provision of residential aged care services in Australia.
REG
AU$7.98
7D
7.5%
1Y
95.6%
Nanosonics
Market Cap: AU$1.2b
Operates as an infection prevention company globally.
NAN
AU$3.85
7D
0.5%
1Y
28.3%